BioRestorative Therapies, Inc. (BRTX)

BioRestorative Therapies Statistics

Total Valuation

BRTX has a market cap or net worth of $9.85 million. The enterprise value is $5.36 million.

Market Cap	9.85M
Enterprise Value	5.36M

Important Dates

The last earnings date was Wednesday, November 12, 2025, after market close.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

BRTX has 8.88 million shares outstanding. The number of shares has increased by 24.38% in one year.

Current Share Class	8.88M
Shares Outstanding	8.88M
Shares Change (YoY)	+24.38%
Shares Change (QoQ)	+4.30%
Owned by Insiders (%)	16.56%
Owned by Institutions (%)	4.48%
Float	6.03M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	24.86
Forward PS	4.12
PB Ratio	4.04
P/TBV Ratio	6.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	13.99
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.37

Current Ratio	1.37
Quick Ratio	1.31
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -207.73% and return on invested capital (ROIC) is -148.19%.

Return on Equity (ROE)	-207.73%
Return on Assets (ROA)	-89.73%
Return on Invested Capital (ROIC)	-148.19%
Return on Capital Employed (ROCE)	-657.55%
Revenue Per Employee	$34,855
Profits Per Employee	-$1.15M
Employee Count	11
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.00% in the last 52 weeks. The beta is 0.08, so BRTX's price volatility has been lower than the market average.

Beta (5Y)	0.08
52-Week Price Change	-26.00%
50-Day Moving Average	1.41
200-Day Moving Average	1.59
Relative Strength Index (RSI)	39.29
Average Volume (20 Days)	81,103

Short Selling Information

The latest short interest is 142,622, so 1.61% of the outstanding shares have been sold short.

Short Interest	142,622
Short Previous Month	138,174
Short % of Shares Out	1.61%
Short % of Float	2.36%
Short Ratio (days to cover)	0.57

Income Statement

In the last 12 months, BRTX had revenue of $383,400 and -$12.67 million in losses. Loss per share was -$1.48.

Revenue	383,400
Gross Profit	357,853
Operating Income	-14.51M
Pretax Income	-12.67M
Net Income	-12.67M
EBITDA	-14.30M
EBIT	-14.51M
Loss Per Share	-$1.48

Balance Sheet

The company has $4.49 million in cash and n/a in debt, giving a net cash position of $4.49 million or $0.51 per share.

Cash & Cash Equivalents	4.49M
Total Debt	n/a
Net Cash	4.49M
Net Cash Per Share	$0.51
Equity (Book Value)	2.21M
Book Value Per Share	0.27
Working Capital	1.27M

Cash Flow

In the last 12 months, operating cash flow was -$10.72 million and capital expenditures -$48,834, giving a free cash flow of -$10.77 million.

Operating Cash Flow	-10.72M
Capital Expenditures	-48,834
Free Cash Flow	-10.77M
FCF Per Share	-$1.21

Margins

Gross Margin	93.34%
Operating Margin	-3,785.07%
Pretax Margin	-3,304.77%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BRTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.38%
Shareholder Yield	-24.38%
Earnings Yield	-128.60%
FCF Yield	-109.32%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	208.85%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 27, 2021. It was a reverse split with a ratio of 1:4,000.

Last Split Date	Oct 27, 2021
Split Type	Reverse
Split Ratio	1:4,000

Scores

BRTX has an Altman Z-Score of -47.37 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-47.37
Piotroski F-Score	2